Rapid changes in epidemiology of inflammatory bowel disease

The Lancet

Volumn 390, Issue 10114, 2017, Pages 2741-2742

  Kamm, Michael A ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FOOD ADDITIVE;

CROHN DISEASE; ENVIRONMENTAL FACTOR; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE PLANNING; HIGH INCOME COUNTRY; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INCIDENCE; INTESTINE FLORA; LOWEST INCOME GROUP; MEDICAL PRACTICE; MEDICAL RESEARCH; MIDDLE INCOME COUNTRY; NOTE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TUBERCULOSIS; ULCERATIVE COLITIS; INFLAMMATORY BOWEL DISEASE;

CROHN DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 85031501515     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)32669-7     Document Type: Note

References (12)

1. Zhao, J, Ng, SC, Lei, Y, et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of “western” disease. Inflamm Bowel Dis 19 (2013), 1839–1845.
2. Prideaux, L, Kamm, MA, De Cruz, P, et al. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. J Gastroenterol Hepatol 27 (2012), 919–927.
3. Ng, SC, Tang, W, Ching, J, et al. Incidence and phenotype of inflammatory bowel disease, based on results from the Asia-Pacific Crohn's and colitis epidemiology study. Gastroenterology 145 (2013), 158–165.
4. Ng, SC, Shi, HY, Hamidi, N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2017 published online Oct 16. http://dx.doi.org/10.1016/S0140-6736(17)32448-0.
5. Molodecky, NA, Soon, IS, Rabi, DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142 (2012), 46–54.
6. Kaplan, GG, Ng, SC, Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152 (2017), 313–321.
7. Kaplan, GG, The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 12 (2015), 720–727.
8. Benchimol, EI, Mack, DR, Guttmann, A, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol 110 (2015), 553–563.
9. Nagao-Kitamoto, H, Shreiner, AB, Gillilland, MG 3rd, et al. Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice. Cell Mol Gastroenterol Hepatol 2 (2016), 468–481.
10. Chassaing, B, Koren, O, Goodrich, JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
11. Hviid, A, Svanström, H, Frisch, M, Antibiotic use and inflammatory bowel diseases in childhood. Gut 60 (2011), 49–54.
12. Kronman, MP, Zaoutis, TE, Haynes, K, Feng, R, Coffin, SE, Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130 (2012), 794–803.